Y2X Topical
Natural health product licensed in Canada
- Other names
- Y2X Chinese brush, Y2X Desensitizers
- Licence holder
- CycTek Inc.
- NPN or DIN-HM
- 80092380
- Status
- Active licence
- Licence date
- 22 May 2019
- Revision date
- Not provided
- Form
- Gel
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
PEG-400, Copolymère de carbomère, Parfum, Extrait de feuilles d'Aloe barbadensis, Eau
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Gel | 1 Tous les jours |
Uses authorised in Canada
For reducing oversensitivity in advance of intercourse. For temporary male genital desensitisation, helping to slow the onset of ejaculation. Helps in temporarily retarding the onset of ejaculation/temporarily slowing the onset of ejaculation/temporarily prolonging the time until ejaculation. Helps in the prevention of premature ejaculation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If the following symptoms appear: weakness, confusion, headache, difficulty breathing and/or pale, gray or blue coloured skin, stop use and consult a health care practitioner. These symptoms may be signs of methemoglobinemia, a rare disorder, which may appear up to 2 hours after use.
- Précautions et mises en garde
Premature ejaculation may be due to a condition requiring medical supervision. If this product, used as directed, does not provide relief, discontinue use and consult a health care practitioner.
- Effets indésirables connus
Hypersensitivity/allergy has been known to occur; in which case, discontinue use.
Source
Official Health Canada record, licence 80092380
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.